Provitro’s endothelial cell growth media were developed to provide endothelial cells with optimal growth conditions in a low-serum environment. Provitro’s basal growth media will be supplemented with FCS less than 5%, an endothelial growth supplement, rec. human EGF and bFGF and hydrocortisone according to the specification of the growth media.
Based on the expertise of provitro and some of our customers, our two endothelial cell growth media are recommended for the cell types listed below:
Endothelial cell growth medium, low serum
Endothelial cell growth medium, advanced, low serum
- HUVEC, human pulmonary artery and human saphenous vein endothelial cells and endothelial cells derived from mouse, rat, rabbit, pig or cattle.
Microvascular endothelial cell growth medium, low serum
Microvascular endothelial cell growth medium, advanced, low serum
- HMVEC; human coronary, lung, brain and aortic endothelial cells. Also useful with endothelial cells derived from mouse, rat, rabbit, pig or cattle.
Endothelial cell growth medium, basal
| OFFER NO |
PRODUCT |
SPECIFICS |
DETAILS |
| 200 0101 |
Endothelial cell growth medium, basal |
basal |
|
Endothelial cell growth medium
| OFFER NO |
PRODUCT |
SPECIFICS |
DETAILS |
| 201 0111 |
Endothelial cell growth medium |
FCS |
|
| 202 0101 |
Endothelial cell growth medium |
HuS |
|
| 211 0101 |
Endothelial cell growth medium |
FCS-kit |
|
| 212 0101 |
Endothelial cell growth medium |
HuS-kit |
|
Supplementation with:
| SUBSTANCE |
FINAL CONC./ML GROWTH MEDIUM |
| FCS or HuS |
00.02 ml |
| ECGS/H (3 mg/ml) |
04.00 μl |
| human rec. EGF |
00.10 ng |
| human rec. bFGF |
01.00 ng |
| Hydrocortisone |
01.00 μg |
| Gentamicin |
50.00 μg |
| Amphotericin B |
50.00 ng |
Endothelial cell growth medium, advanced
| OFFER NO |
PRODUCT |
SPECIFICS |
DETAILS |
| 201 1101 |
Endothelial cell growth medium, advanced |
FCS |
|
| 202 1101 |
Endothelial cell growth medium, advanced |
HuS |
|
| 211 1101 |
Endothelial cell growth medium, advanced |
FCS-kit |
|
| 212 1101 |
Endothelial cell growth medium, advanced |
HuS-kit |
|
Supplementation with:
| SUBSTANCE |
FINAL CONC./ML GROWTH MEDIUM |
| FCS or HuS |
00.02 ml |
| Heparin |
22.50 μg |
| human rec. EGF |
05.00 ng |
| human rec. bFGF |
10.00 ng |
| human rec. VEGF |
00.50 ng |
| human rec. R3-IGF-1 |
20.00 ng |
| Ascorbic acid |
01.00 μg |
| Hydrocortisone |
00.20 μg |
| Gentamicin |
50.00 μg |
| Amphothericin B |
50.00 ng |
Microvascular endothelial cell growth medium, basal
| OFFER NO |
PRODUCT |
SPECIFICS |
DETAILS |
| 200 0102 |
Microvascular endothelial cell growth medium, basal |
basal |
|
Microvascular endothelial cell growth medium
| OFFER NO |
PRODUCT |
SPECIFICS |
DETAILS |
| 201 0112 |
Microvascular endothelial cell growth medium |
FCS |
|
| 202 0102 |
Microvascular endothelial cell growth medium |
HuS |
|
| 211 0102 |
Microvascular endothelial cell growth medium |
FCS-kit |
|
| 212 0102 |
Microvascular endothelial cell growth medium |
HuS-kit |
|
Supplementation with:
| SUBSTANCE |
FINAL CONC./ML GROWTH MEDIUM |
| FCS or HuS |
00.05 ml |
| ECGS/H (3 mg/ml) |
04.00 μl |
| human rec. EGF |
10.00 ng |
| Hydrocortisone |
01.00 μg |
| Gentamicin |
50.00 μg |
| Amphotericin B |
50.00 ng |
Microvascular endothelial cell growth medium, advanced
| OFFER NO |
PRODUCT |
SPECIFICS |
DETAILS |
| 201 1102 |
Microvascular endothelial cell growth medium, advanced |
FCS |
|
| 202 1102 |
Microvascular endothelial cell growth medium, advanced |
HuS |
|
| 211 1102 |
Microvascular endothelial cell growth medium, advanced |
FCS-kit |
|
| 212 1102 |
Microvascular endothelial cell growth medium, advanced |
HuS-kit |
|
Supplementation with:
| SUBSTANCE |
FINAL CONC./ML GROWTH MEDIUM |
| FCS or HuS |
00.05 ml |
| human rec. EGF |
05.00 ng |
| human rec. bFGF |
10.00 ng |
| human rec. R3-IGF-1 |
20.00 ng |
| Ascorbic acid |
01.00 μg |
| Hydrocortisone |
00.20 μg |
| Gentamicin |
50.00 μg |
| Ampho B |
50.00 ng |
